A detailed history of Price T Rowe Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 10,257,962 shares of ABBV stock, worth $1.83 Billion. This represents 0.23% of its overall portfolio holdings.

Number of Shares
10,257,962
Previous 10,943,208 6.26%
Holding current value
$1.83 Billion
Previous $1.88 Billion 7.93%
% of portfolio
0.23%
Previous 0.22%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $112 Million - $137 Million
-685,246 Reduced 6.26%
10,257,962 $2.03 Billion
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $30.8 Million - $36 Million
199,018 Added 1.85%
10,943,208 $1.88 Billion
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $206 Million - $235 Million
1,291,201 Added 13.66%
10,744,190 $1.96 Billion
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $463 Million - $521 Million
-3,361,579 Reduced 26.23%
9,452,989 $1.46 Billion
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $46.8 Million - $54.2 Million
-350,146 Reduced 2.66%
12,814,568 $1.91 Billion
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $585 Million - $727 Million
-4,411,166 Reduced 25.1%
13,164,714 $1.77 Billion
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $412 Million - $474 Million
-2,847,220 Reduced 13.94%
17,575,880 $2.8 Billion
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $567 Million - $680 Million
-4,098,236 Reduced 16.71%
20,423,100 $3.3 Billion
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $844 Million - $968 Million
-6,286,462 Reduced 20.41%
24,521,336 $3.29 Billion
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $815 Million - $1.04 Billion
-5,924,329 Reduced 16.13%
30,807,798 $4.72 Billion
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $547 Million - $679 Million
4,146,214 Added 12.72%
36,732,127 $5.95 Billion
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $685 Million - $867 Million
6,377,892 Added 24.34%
32,585,913 $4.41 Billion
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $297 Million - $337 Million
-2,791,314 Reduced 9.63%
26,208,021 $2.83 Billion
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $338 Million - $377 Million
-3,212,860 Reduced 9.97%
28,999,335 $3.27 Billion
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $30.3 Million - $33.4 Million
-296,222 Reduced 0.91%
32,212,195 $3.49 Billion
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $2.62 Billion - $3.53 Billion
32,508,417 New
32,508,417 $3.48 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.